<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Wen Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The prognostic significance of long non-coding RNA ST8SIA6-AS1 remains ambiguous, and its biological role in prostate cancer (PCa) has not been thoroughly investigated. This study seeks to conduct a comprehensive meta-analysis to assess the clinical relevance of ST8SIA6-AS1 across different malignancies, with a particular emphasis on elucidating its functions in the advancement of PCa.&lt;h4>Methods&lt;/h4>Systematic searches were conducted in the PubMed, Embase, and Web of Science databases to select studies that met the criteria. Data, including hazard ratios (HR) with 95% confidence intervals (95% CI) and clinical pathological parameters, were collected. Subgroup analyses were performed based on sample size and tumor type. The expression profile analysis of PCa tissues was </pubmed_abstract><journal>Frontiers in genetics</journal><pagination>1648077</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12634032</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer.</pubmed_title><pmcid>PMC12634032</pmcid><pubmed_authors>Wen Y</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Zhan S</pubmed_authors><pubmed_authors>Chen G</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer.</name><description>&lt;h4>Background&lt;/h4>The prognostic significance of long non-coding RNA ST8SIA6-AS1 remains ambiguous, and its biological role in prostate cancer (PCa) has not been thoroughly investigated. This study seeks to conduct a comprehensive meta-analysis to assess the clinical relevance of ST8SIA6-AS1 across different malignancies, with a particular emphasis on elucidating its functions in the advancement of PCa.&lt;h4>Methods&lt;/h4>Systematic searches were conducted in the PubMed, Embase, and Web of Science databases to select studies that met the criteria. Data, including hazard ratios (HR) with 95% confidence intervals (95% CI) and clinical pathological parameters, were collected. Subgroup analyses were performed based on sample size and tumor type. The expression profile analysis of PCa tissues was </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-19T03:21:16.245Z</modification><creation>2026-05-19T03:11:49.661Z</creation></dates><accession>S-EPMC12634032</accession><cross_references><pubmed>41282486</pubmed><doi>10.3389/fgene.2025.1648077</doi></cross_references></HashMap>